miR-375 also targets the adiponectin receptor 2 (AdipoR2) protein, an important regulator of glucose and lipid metabolism, by activating the PPAR-α pathway, allowing it to reduce insulin sensitivity and steatosis [67]. The gene discussed is ADIPOR2; the disease is steatosis.